Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.
Isao Sakurada, Toshiya Endo, Katsuyoshi Hikita, Tomokazu Hirabayashi, Yoshitaka Hosaka, Yutaka Kato, Yoshitaka Maeda, Shigeki Matsumoto, Takashi Mizuno, Hiroshi Nagasue, Teruyuki Nishimura, Shunsuke Shimada, Mikihiko Shinozaki, Keiko Taguchi, Katsutoshi Takeuchi, Tooru Yokoyama, Alan Hruza, Paul Reichert, Ting Zhang, Harold B Wood, Kazunari Nakao, Shoji Furusako
Bioorganic & medicinal chemistry letters 2017 Jun 01Using structure based drug design, novel aminobenzisoxazoles as coagulation factor IXa inhibitors were designed and synthesized. Highly selective inhibition of FIXa over FXa was demonstrated. Anticoagulation profile of selected compounds was evaluated by aPTT and PT tests. In vitro ADMET and pharmacokinetic (PK) profiles were also evaluated. Copyright © 2017 Elsevier Ltd. All rights reserved.
Citation
Isao Sakurada, Toshiya Endo, Katsuyoshi Hikita, Tomokazu Hirabayashi, Yoshitaka Hosaka, Yutaka Kato, Yoshitaka Maeda, Shigeki Matsumoto, Takashi Mizuno, Hiroshi Nagasue, Teruyuki Nishimura, Shunsuke Shimada, Mikihiko Shinozaki, Keiko Taguchi, Katsutoshi Takeuchi, Tooru Yokoyama, Alan Hruza, Paul Reichert, Ting Zhang, Harold B Wood, Kazunari Nakao, Shoji Furusako. Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors. Bioorganic & medicinal chemistry letters. 2017 Jun 01;27(11):2622-2628
Mesh Tags
Substances
PMID: 28408226
View Full Text
